Magnetic Resonance Perfusion
GPTKB entity
Statements (48)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Medical_Imaging_Technique
|
| gptkbp:advantage |
Non-invasive
No ionizing radiation |
| gptkbp:alsoKnownAs |
MR Perfusion
Perfusion MRI |
| gptkbp:canBe |
Oncology
Brain tumor grading Dementia assessment Epilepsy evaluation Monitoring therapy response Multiple sclerosis monitoring Myocardial perfusion imaging Peripheral vascular disease assessment Pre-surgical planning Research applications Stroke penumbra identification Traumatic brain injury evaluation |
| gptkbp:canBeNonContrast |
Arterial Spin Labeling
|
| gptkbp:canUseContrastAgent |
gptkb:Gadolinium-based_contrast_agent
|
| gptkbp:contraindication |
MRI-incompatible implants
Severe renal impairment (for contrast studies) |
| gptkbp:developedBy |
Late 20th century
|
| gptkbp:field |
gptkb:Radiology
Cardiology Neuroradiology |
| gptkbp:limitation |
Potential nephrogenic systemic fibrosis with gadolinium
Limited availability in some settings Susceptible to motion artifacts |
| gptkbp:measures |
Cerebral blood flow (CBF)
Cerebral blood volume (CBV) Mean transit time (MTT) Time to peak (TTP) |
| gptkbp:performedBy |
Radiologist
Technologist |
| gptkbp:relatedTo |
Arterial Spin Labeling
Dynamic Contrast Enhanced MRI Dynamic Susceptibility Contrast MRI |
| gptkbp:requires |
gptkb:MRI_scanner
Specialized software |
| gptkbp:usedFor |
Assessing cerebral perfusion
Cardiac perfusion assessment Evaluating stroke Measuring blood flow in tissues Tumor characterization |
| gptkbp:usesModality |
gptkb:Magnetic_Resonance_Imaging
|
| gptkbp:bfsParent |
gptkb:MRP
|
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
Magnetic Resonance Perfusion
|